127 related articles for article (PubMed ID: 34481696)
1. Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response.
Azam JM; Saitta B; Bonner K; Ferrari MJ; Pulliam JRC
Vaccine; 2021 Sep; 39(40):5845-5853. PubMed ID: 34481696
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the stability of measles vaccine out of the cold chain under extended controlled temperature conditions.
Juan-Giner A; Alsalhani A; Panunzi I; Lambert V; Van Herp M; Gairola S
Vaccine; 2020 Mar; 38(11):2473-2477. PubMed ID: 32046890
[TBL] [Abstract][Full Text] [Related]
3. The value of tailoring vial sizes to populations and locations.
Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
[TBL] [Abstract][Full Text] [Related]
4. Lessons learnt from a measles outbreak in Madang Province, Papua New Guinea, June 2014 - March 2015.
Kamac K; Paterson B; Flint J
Western Pac Surveill Response J; 2017; 8(1):1-5. PubMed ID: 28409053
[TBL] [Abstract][Full Text] [Related]
5. Measles Outbreak Associated with Vaccine Failure in Adults--Federated States of Micronesia, February-August 2014.
Breakwell L; Moturi E; Helgenberger L; Gopalani SV; Hales C; Lam E; Sharapov U; Larzelere M; Johnson E; Masao C; Setik E; Barrow L; Dolan S; Chen TH; Patel M; Rota P; Hickman C; Bellini W; Seward J; Wallace G; Papania M
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(38):1088-92. PubMed ID: 26421903
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
Kolwaite AR; Xeuatvongsa A; Ramirez-Gonzalez A; Wannemuehler K; Vongxay V; Vilayvone V; Hennessey K; Patel MK
Vaccine; 2016 Jun; 34(28):3324-30. PubMed ID: 27040399
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the cold chain technology in South-East, Nigeria using Immunogenicity study on the measles vaccines.
Oli AN; Agu RU; Ihekwereme CP; Esimone CO
Pan Afr Med J; 2017; 27(Suppl 3):28. PubMed ID: 29296163
[TBL] [Abstract][Full Text] [Related]
8. Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.
Assi TM; Brown ST; Djibo A; Norman BA; Rajgopal J; Welling JS; Chen SI; Bailey RR; Kone S; Kenea H; Connor DL; Wateska AR; Jana A; Wisniewski SR; Van Panhuis WG; Burke DS; Lee BY
BMC Public Health; 2011 Jun; 11():425. PubMed ID: 21635774
[TBL] [Abstract][Full Text] [Related]
9. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
[TBL] [Abstract][Full Text] [Related]
10. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
11. Measles outbreak investigation in Guji zone of Oromia Region, Ethiopia.
Belda K; Tegegne AA; Mersha AM; Bayenessagne MG; Hussein I; Bezabeh B
Pan Afr Med J; 2017; 27(Suppl 2):9. PubMed ID: 28983397
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of mass measles campaign in AILA-affected areas of West Bengal.
Dasgupta S; Bagchi SN; Ghosh P; Sardar JC; Roy AS; Sau M
Indian J Public Health; 2010; 54(4):224-7. PubMed ID: 21372374
[TBL] [Abstract][Full Text] [Related]
13. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
Breakwell L; Anga J; Dadari I; Sadr-Azodi N; Ogaoga D; Patel M
Vaccine; 2017 May; 35(21):2770-2774. PubMed ID: 28431814
[TBL] [Abstract][Full Text] [Related]
15. Measles epidemiology and outbreak response immunization in a rural community in Peru.
Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
[TBL] [Abstract][Full Text] [Related]
16. Madagascar 2018-2019 measles outbreak response: main strategic areas.
Sodjinou VD; Douba A; Nimpa MM; Masembe YV; Randria M; Ndiaye CF
Pan Afr Med J; 2020; 37():20. PubMed ID: 33062122
[TBL] [Abstract][Full Text] [Related]
17. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.
Ma C; Li F; Zheng X; Zhang H; Duan M; Yang Y; Hao L; Su Q; Rodewald L; Guo B; Xiao S; Wang H; Li L; Li J; Luo H; Gao L
BMC Infect Dis; 2015 Jan; 15():23. PubMed ID: 25608672
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and timing of vaccination during school measles outbreak.
Bonačić Marinović AA; Swaan C; Wichmann O; van Steenbergen J; Kretzschmar M
Emerg Infect Dis; 2012 Sep; 18(9):1405-13. PubMed ID: 22931850
[TBL] [Abstract][Full Text] [Related]
19. Towards eradication of measles virus: global progress and strategy evaluation.
Nokes DJ; Williams JR; Butler AR
Vet Microbiol; 1995 May; 44(2-4):333-50. PubMed ID: 8588328
[TBL] [Abstract][Full Text] [Related]
20. Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment.
Heyerdahl LW; Ngwira B; Demolis R; Nyirenda G; Mwesawina M; Rafael F; Cavailler P; Bernard Le Gargasson J; Mengel MA; Gessner BD; Guillermet E
Vaccine; 2018 Oct; 36(44):6491-6496. PubMed ID: 29126808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
